1. Overview of thioredoxin system and targeted therapies for acute leukemia
   Weiling Xie et al, 2019, Mitochondrion CrossRef
2. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
   Mohammed I. Y. Elmallah et al, 2019, Cancers CrossRef
3. Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B-cell lymphoma cells
   LINA ZHANG et al, 2016, Molecular Medicine Reports CrossRef
4. Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis
   Dae-Hee Lee et al, 2014, Biochemical and Biophysical Research Communications CrossRef
5. Myeloid Differentiation Increases Resistance of Leukemic Cells to TRAIL-Induced Death by Reducing the Expression of DR4 and DR5 Receptors
   Ya. V. Lomovskaya et al, 2023, Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology CrossRef
6. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies
   Arnaud Gilles et al, 2020, Cells CrossRef
7. Effect of Homoharringtonine as a Combined Regimen for Acute Myeloid Leukemia
   Abinaya Muralidharan et al, 2021, Journal of Pharmacology and Pharmacotherapeutics CrossRef
8. Investigating the synergistic potential of TRAIL and SAHA in inducing apoptosis in MOLT-4 cancer cells
   Masoud Mohammad Mirzapour et al, 2023, Biochemical and Biophysical Research Communications CrossRef
9. Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death
   U Beyer et al, 2016, Cell Death & Differentiation CrossRef
10. Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
    Sonia Abou Najem et al, 2019, Cells CrossRef
11. Ribosome-Directed Therapies in Cancer
    Gazmend Temaj et al, 2022, Biomedicines CrossRef
12. TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies
    Adel Naimi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
13. Natural Agents-Mediated Targeting of Histone Deacetylases
    Ammad Ahmad Farooqi et al, 2018, Archivum Immunologiae et Therapiae Experimentalis CrossRef
14. Regulation of anoikis by extrinsic death receptor pathways
    Ying-Hao Han et al, 2023, Cell Communication and Signaling CrossRef
15. Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
    XIUJUN HAN et al, 2015, Molecular Medicine Reports CrossRef
16. The Metabolic Signature of AML Cells Treated With Homoharringtonine
    Yulong Zhang et al, 2022, Frontiers in Oncology CrossRef
17. DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS
    Jung Soon Hwang et al, 2017, Food and Chemical Toxicology CrossRef